今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

国产动漫《遮天》发布主题曲MV 刘欢萧敬腾热血开唱，演绎逆天改命史诗

北京 - 2023年5月3日，由企鹅影视、天蚕土豆工作室联合出品的国产大型3D玄幻动画《遮天》正式发布主题曲MV《遮天》，由著名歌唱家刘欢和人气歌手萧敬腾联袂献唱，以磅礴大气的旋律和热血激昂的歌词，完美诠释了原作中波澜壮阔的剧情和人物逆天改命的史诗篇章。

MV以唯美的大漠风光和恢弘的仙侠场景开篇，刘欢浑厚深沉的嗓音唱出天地之广阔、命运之无常，将听众瞬间带入《遮天》的浩瀚世界。随后，画面转入激烈的战斗场面，萧敬腾高亢嘹亮的歌声则唱出了主角叶凡不屈不挠、勇往直前的精神，以及他与命运抗争、逆天改命的决心。

《遮天》是著名作家天蚕土豆的代表作，也是起点中文网白银大神作品，被誉为“东方玄幻经典之作”。小说讲述了叶凡在末法时代崛起，一路修行、逆天改命，最终踏上巅峰的故事。动画版《遮天》由企鹅影视和天蚕土豆工作室联合制作，力求还原原作的恢弘世界观和热血剧情，并以精良的制作水准为观众带来极致的视听享受。

主题曲《遮天》由著名音乐人唐汉霄作曲、作词，并邀请到刘欢和萧敬腾两位重量级歌手献唱。刘欢作为一代歌坛巨匠，其深厚的歌唱功底和磅礴的气势完美契合了《遮天》的史诗气质。而萧敬腾则以其高亢嘹亮的嗓音和充满力量的演唱，将主角叶凡的热血和不屈精神演绎得淋漓尽致。

MV的发布，不仅为动画版《遮天》增添了浓厚的气氛，也让更多观众提前感受到了这部作品的魅力。据悉，动画版《遮天》将于近期登陆各大视频平台，敬请期待。